Drug Type Small molecule drug |
Synonyms BY 101298, BY 1298, BY-101298 + [3] |
Target |
Action inhibitors |
Mechanism PRKDC inhibitors(DNA-dependent protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | China | 19 Jul 2024 | |
Advanced Malignant Solid Neoplasm | Phase 2 | China | 19 Jul 2024 | |
Brain metastases | Phase 2 | China | 15 May 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 2 | China | 15 May 2024 | |
Primary Malignant Liver Neoplasm | Phase 1 | China | 25 Apr 2023 |